- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
The medical devices company is likely to stick to small- to mid- sized M&A unless it finds itself the target.
St. Jude shares deserve to be higher ahead of the merger with Abbott Labs. Here's why.